A PEAR1 polymorphism (rs12041331) is associated with risk of coronary artery aneurysm in Kawasaki disease.


Journal

Annals of human genetics
ISSN: 1469-1809
Titre abrégé: Ann Hum Genet
Pays: England
ID NLM: 0416661

Informations de publication

Date de publication:
01 2019
Historique:
received: 01 03 2018
revised: 24 07 2018
accepted: 25 07 2018
pubmed: 27 9 2018
medline: 20 12 2019
entrez: 27 9 2018
Statut: ppublish

Résumé

Kawasaki disease (KD) is an acute systemic vasculitis that is most seriously complicated by coronary artery aneurysm (CAA). The polymorphisms of platelet endothelial aggregation receptor 1 (PEAR1), notably rs12041331 and rs12566888, were found to be closely related to cardiac disease. However, little is known regarding the connection between PEAR1 and KD. In this study, we genotyped PEAR1 rs12566888 and rs12041331 in 637 healthy infants and 694 KD patients (74 with CAA). Subsequently, odds ratio (OR) and 95% confidence interval (CI) were calculated to assess the strength of their relationships. No significant differences in the frequency of rs12566888 or rs12041331 in PEAR1 were observed between KD and healthy controls. However, regardless of the statistical combination of rs12566888 genotype, the rs12041331 recessive inheritance model was associated with an increased risk of CAA after Bonferroni correction (for rs12041331, AA vs. GG/GA: adjusted OR = 2.37, 95% CI = 1.41-4.01, P = 0.009; combination of two recessive genotypes vs. combination of 0-1 recessive genotypes: adjusted OR = 2.39, 95% CI = 1.42-4.04, P = 0.009). This study suggests for the first time that PEAR1 polymorphisms did not indicate susceptibility for KD occurrence but the rs12041331 polymorphism was associated with increased risk of CAA formation in KD, and the functions of the gene warrant further research.

Identifiants

pubmed: 30256383
doi: 10.1111/ahg.12285
doi:

Substances chimiques

PEAR1 protein, human 0
Receptors, Cell Surface 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

54-62

Subventions

Organisme : National Key Basic Research and Development Program (973 Program)
ID : 2015CB755402
Pays : International
Organisme : Guangdong Natural Science Fund
ID : 2016A030313836
Pays : International
Organisme : Guangdong Science and Technology Project
ID : 2014A020212613
Pays : International
Organisme : Guangdong Science and Technology Project
ID : 2014A020212012
Pays : International
Organisme : Guangdong Science and Technology Project
ID : 2014A020212023
Pays : International
Organisme : Guangzhou Science and Technology Program Project
ID : 201510010287
Pays : International
Organisme : Guangzhou Science and Technology Program Project
ID : 201510010159
Pays : International
Organisme : Guangzhou Science and Technology Program Project
ID : 201607010011
Pays : International
Organisme : Guangzhou Science and Technology Program Project
ID : 201804010035
Pays : International
Organisme : Guangzhou Medical And Health Technology Projects
ID : 20171A011260
Pays : International
Organisme : Guangzhou Medical And Health Technology Projects
ID : 20161A010030
Pays : International
Organisme : Guangzhou Institute of Pediatrics/Guangzhou Women and Children's Medical Center Fund
ID : YIP-2018-019
Pays : International

Informations de copyright

© 2018 John Wiley & Sons Ltd/University College London.

Auteurs

Lei Pi (L)

Department of Clinical Biological Resource Bank, Guangzhou Institute of Pediatrics, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China.

Yufen Xu (Y)

Department of Clinical Biological Resource Bank, Guangzhou Institute of Pediatrics, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China.

Lanyan Fu (L)

Department of Clinical Biological Resource Bank, Guangzhou Institute of Pediatrics, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China.

Li Zhang (L)

Department of Cardiology, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China.

Yunfeng Liu (Y)

Department of Clinical Lab, Guangzhou Institute of Pediatrics, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China.

Huazhong Zhou (H)

Department of Clinical Biological Resource Bank, Guangzhou Institute of Pediatrics, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China.

Di Che (D)

Department of Clinical Biological Resource Bank, Guangzhou Institute of Pediatrics, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China.

Xiaoqiong Gu (X)

Department of Clinical Biological Resource Bank, Guangzhou Institute of Pediatrics, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China.
Department of Clinical Lab, Guangzhou Institute of Pediatrics, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH